Biotech's Lawsuit With Eli Lilly Might Catalyze Stock
Source: Streetwise Reports (03/27/2024)
Nektar Therapeutics has commenced a Phase 2b clinical trial evaluating its lead product candidate rezpegaldesleukin in patients with severe to very severe alopecia areata. In other news, Nektar has a lawsuit pending against Eli Lilly & Co. Read on to see what two experts have to say about this biotech stock.
read more >
Minnesota AI Co. Funded To Develop AI Approach to Health Equity
Source: Streetwise Reports (03/27/2024)
Treatment.com AI Inc. announced it has been granted funding from The National Institute of Health (NIH) to create a "culturally sensitive AI approach" when it comes to receiving familial medical histories for patients. Read on to see the medical need for this type of service and why one technical analysts is optimistic about this stock.
read more >
Gold Stock Shares Goal Updates and Upcoming Catalysts
Source: Streetwise Reports (03/27/2024)
Seabridge Gold Inc. recently put out a report card, detailing which of its 2023 goals were met, and shared information about upcoming catalysts, including a potential JV partner.
read more >
Lithium Tech Co. Starts Building Water-Saving Extraction Demo
Source: Streetwise Reports (03/27/2024)
Lithos Group Ltd. announced it has started manufacturing a demonstration-scale modular field unit using its AcQUA technology, which allows lithium to be extracted from brine without evaporation ponds. Find out why one analyst says the stock is about to start a bull market.
read more >
Gold Exploration Co. Reveals Major Find at Key Nevada Project
Source: Streetwise Reports (03/27/2024)
Western Exploration Inc. CEO Darcy Marud gave an insight into recent updates at PDAC 2024.
read more >